Bailard Inc. Has $816,000 Holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Bailard Inc. boosted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 250.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,720 shares of the real estate investment trust's stock after buying an additional 33,383 shares during the period. Bailard Inc.'s holdings in Sabra Healthcare REIT were worth $816,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Sabra Healthcare REIT during the 4th quarter worth about $48,950,000. Northern Trust Corp grew its stake in shares of Sabra Healthcare REIT by 27.7% in the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Thrivent Financial for Lutherans raised its position in Sabra Healthcare REIT by 95.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,816,217 shares of the real estate investment trust's stock worth $31,457,000 after acquiring an additional 888,908 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Sabra Healthcare REIT in the fourth quarter worth $14,241,000. Finally, Wellington Management Group LLP raised its position in Sabra Healthcare REIT by 33.7% in the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock worth $55,511,000 after acquiring an additional 808,207 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Insider Buying and Selling

In other news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director directly owned 64,725 shares in the company, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.20% of the stock is currently owned by company insiders.

Sabra Healthcare REIT Trading Down 0.1%

Shares of NASDAQ:SBRA traded down $0.01 during mid-day trading on Friday, hitting $18.07. The stock had a trading volume of 2,222,382 shares, compared to its average volume of 2,308,811. The company has a market cap of $4.30 billion, a PE ratio of 30.63, a P/E/G ratio of 1.50 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. The company's 50 day moving average is $18.04 and its 200-day moving average is $17.41.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business had revenue of $183.54 million for the quarter, compared to the consensus estimate of $180.23 million. During the same quarter last year, the firm earned $0.35 EPS. Sabra Healthcare REIT's revenue for the quarter was up 10.1% on a year-over-year basis. On average, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.64%. Sabra Healthcare REIT's payout ratio is 203.39%.

Analyst Ratings Changes

Separately, Scotiabank upped their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of "Moderate Buy" and a consensus target price of $19.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.